查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631156

植入周圍炎市場規模、佔有率、趨勢分析報告：按方法類型、地區、細分市場預測，2025-2030 年

Peri-implantitis Market Size, Share & Trends Analysis Report By Method Type (Surgical (Bone Regeneration, Open Flap Debridement, Implantoplasty), Non-surgical (Laser Debridement)), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

植體植入炎市場成長與趨勢

根據 Grand View Research, Inc. 的最新報告，全球植體周圍植入市場規模預計在 2025 年至 2030 年間以 9.1% 的複合年成長率成長，到 2030 年達到 17.5 億美元。

植體周圍植入是一種部位特異性破壞性發炎性疾病，影響骨整合植入周圍的軟組織和硬組織，導致骨質流失和植入袋的形成。據報道，10 年內人工植牙的成功率為 92% 至 98%。然而，患有牙周炎病史的患者數量不斷增加、與有效治療植體周圍植入相關的技術進步的出現以及吸煙和糖尿病患者數量不斷增加等因素正在推動市場成長。

隨著全球植入的植入數量的增加，植體植入併發症的發生率預計也會增加。根據 NCBI 的數據，1999 年至 2017 年間，美國的植入普及率每年成長率為 14.0%。英國每年約有 26 萬顆植入進行植入，這表明對人工植牙的需求正在成長。隨著植入成為常見的治療方法，植入黏膜炎、植體植入相關疾病的盛行率呈現正相關性。此外，根據疾病預防控制中心的數據，2019 年美國30 歲成年人中 47.2% 患有某種形式的牙周疾病。男性患有這種疾病的幾率比女性更高，因為男性更容易受到吸煙和糖尿病等健康問題的影響。雷射清創、引導骨再生 (GBR) 和診斷遺傳生物標記技術等技術的進步預計將推動植入炎治療市場的成長。

Peri -植體炎市場報告重點

  • 2024 年，外科手術領域佔據了市場主導地位，因為外科清創手術效率高，且被認為是治療植體周圍植入最有效的技術。
  • 預計非手術技術雷射清創將在預測期內實現最高成長，因為它能夠有效地選擇性去除結石並帶來更好的臨床效果。
  • 由於植體周圍植入治療技術的不斷進步，歐洲將在 2024 年佔據市場主導地位。
  • 由於人口老化加劇、人們對植入和相關疾病的認知不斷提高以及技術的快速進步，預計亞太地區將在預測期內實現最高的複合年成長率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章植入周圍炎市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章 植體植入炎市場：依方法類型、業務分析

  • 2024 年和 2030 年方法類型市場佔有率
  • 方法類型細分儀表板
  • 2018 年至 2030 年按方法類型分類的市場規模、預測與趨勢分析
  • 外科
  • 非手術

第 5 章 植體植入炎市場：區域、估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 按國家/地區，2018 年至 2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區，2018 年至 2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Pfizer Inc.
    • Cadila Pharmaceuticals
    • GaronitPharma
    • Basic Pharma Life Science Pvt Ltd.
    • Prachi Pharmaceuticals Private Limited.
    • Geistlich Pharma India Pvt. Ltd.
    • Healthy Life Pharma Private Limited.
    • Zimmer Biomet.
    • Institut Straumann AG
    • Dentsply Sirona
Product Code: GVR-4-68039-099-7

Peri-implantitis Market Growth & Trends:

The global peri-implantitis market size is expected to reach USD 1.75 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%-98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.

The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.

Peri-implantitis Market Report Highlights:

  • The surgical segment dominated the market in 2024 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
  • Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
  • Europe dominated the market in 2024 owing to the rising technological advancements for peri-implantitis treatment
  • In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Method Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Peri-implantitis Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Peri-implantitis Market: Method Type Business Analysis

  • 4.1. Method Type Market Share, 2024 & 2030
  • 4.2. Method Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Method Type, 2018 to 2030 (USD Billion)
  • 4.4. Surgical
    • 4.4.1. Surgical Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Bone Regeneration
      • 4.4.2.1. Bone Regeneration Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Open Flap Debridement
      • 4.4.3.1. Open Flap Debridement Market, 2018 - 2030 (USD Billion)
    • 4.4.4. Implantoplasty
      • 4.4.4.1. Implantoplasty Market, 2018 - 2030 (USD Billion)
  • 4.5. Non-surgical
    • 4.5.1. Non-surgical Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Mechanical Debridement
      • 4.5.2.1. Mechanical Debridement Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Laser Debridement
      • 4.5.3.1. Laser Debridement Market, 2018 - 2030 (USD Billion)
    • 4.5.4. Antibiotics
      • 4.5.4.1. Antibiotics Market, 2018 - 2030 (USD Billion)
    • 4.5.5. Others
      • 4.5.5.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Peri-implantitis Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Europe
    • 5.5.1. Europe Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Latin America
    • 5.7.1. Latin America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. MEA
    • 5.8.1. MEA Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Pfizer Inc.
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Method Type Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Cadila Pharmaceuticals
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Method Type Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. GaronitPharma
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Method Type Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Basic Pharma Life Science Pvt Ltd.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Method Type Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. Prachi Pharmaceuticals Private Limited.
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Method Type Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. Geistlich Pharma India Pvt. Ltd.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Method Type Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. Healthy Life Pharma Private Limited.
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Method Type Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. Zimmer Biomet.
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Method Type Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. Institut Straumann AG
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Method Type Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. Dentsply Sirona
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Method Type Benchmarking
      • 6.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global peri-implantitis market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 5 North America peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 6 North America peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 7 U.S. peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 8 Canada peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 9 Mexico peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 10 Europe peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 11 Europe peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 12 UK peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 13 Germany peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 14 France peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 15 Italy peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 16 Spain peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 17 Norway peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 18 Denmark peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 19 Sweden peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 20 Asia Pacific peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 21 Asia Pacific peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 22 Japan peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 23 China peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 24 India peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 25 Australia peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 26 South Korea peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 27 Thailand peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 28 Latin America peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 29 Latin America peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 30 Brazil peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 31 Argentina peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 32 Middle East & Africa peri-implantitis market, by country, 2018 - 2030 (USD Billion)
  • Table 33 Middle East & Africa peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 34 South Africa peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 35 Saudi Arabia peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 36 UAE peri-implantitis market, by method type, 2018 - 2030 (USD Billion)
  • Table 37 Kuwait peri-implantitis market, by method type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Peri-implantitis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Method type outlook (USD Billion)
  • Fig. 10 Transportation mode outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Peri-implantitis market dynamics
  • Fig. 13 Peri-implantitis market: Porter's five forces analysis
  • Fig. 14 Peri-implantitis market: PESTLE analysis
  • Fig. 15 Peri-implantitis market: Method type segment dashboard
  • Fig. 16 Peri-implantitis market: Method type market share analysis, 2024 & 2030
  • Fig. 17 Surgical market, 2018 - 2030 (USD Billion)
  • Fig. 18 Bone regeneration market, 2018 - 2030 (USD Billion)
  • Fig. 19 Open flap debridement market, 2018 - 2030 (USD Billion)
  • Fig. 20 Implantoplasty market, 2018 - 2030 (USD Billion)
  • Fig. 21 Non-surgical market, 2018 - 2030 (USD Billion)
  • Fig. 22 Mechanical debridement market, 2018 - 2030 (USD Billion)
  • Fig. 23 Laser debridement market, 2018 - 2030 (USD Billion)
  • Fig. 24 Antibiotics market, 2018 - 2030 (USD Billion)
  • Fig. 25 Others market, 2018 - 2030 (USD Billion)
  • Fig. 26 Peri-implantitis market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 35 Europe peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 40 France country dynamics
  • Fig. 41 France peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 52 Asia Pacific peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 55 China country dynamics
  • Fig. 56 China peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 57 India country dynamics
  • Fig. 58 India peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 65 Latin America peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 70 MEA peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait peri-implantitis market, 2018 - 2030 (USD Billion)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework